Erratum to: Targ Oncol (2015) 10:565–573
DOI 10.1007/s11523-015-0364-y
A funding statement was omitted from the original publication of this article.
Page 572: The Acknowledgements, which previously read:
“This work was supported by the National Natural Science Foundation of China (21202100) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040302).”
should read:
“This work was supported by the Chinese Ministry of Science and Technology (2013CB967402, granted to Li Li), the National Natural Science Foundation of China (21202100) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040302).”
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s11523-015-0364-y.
Rights and permissions
About this article
Cite this article
Shi, Y., Sun, L., Chen, G. et al. Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines. Targ Oncol 12, 263 (2017). https://doi.org/10.1007/s11523-017-0475-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11523-017-0475-8